Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;21(3):e441-8.
doi: 10.3747/co.21.1843.

Use of screening tests, diagnosis wait times, and wait-related satisfaction in breast and prostate cancer

M Mathews  1 , D Ryan  1 , V Gadag  1 , R West  1
Affiliations

Use of screening tests, diagnosis wait times, and wait-related satisfaction in breast and prostate cancer

M Mathews et al. Curr Oncol. 2014 Jun.

Abstract

Background: Understanding factors relating to the perception of wait time by patients is key to improving the patient experience.

Methods: We surveyed 122 breast and 90 prostate cancer patients presenting at clinics or listed on the cancer registry in Newfoundland and Labrador and reviewed their charts. We compared the wait time (first visit to diagnosis) and the wait-related satisfaction for breast and prostate cancer patients who received regular screening tests and whose cancer was screening test-detected ("screen/screen"); who received regular screening tests and whose cancer was symptomatic ("screen/symptomatic"); who did not receive regular screening tests and whose cancer was screen test-detected ("no screen/screen"); and who did not receive regular screening tests and whose cancer was symptomatic ("no screen/symptomatic").

Results: Although there were no group differences with respect to having a long wait (greater than the median of 47.5 days) for breast cancer patients (47.8% screen/screen, 54.7% screen/symptomatic, 50.0% no screen/ screen, 40.0% no screen/symptomatic; p = 0.814), a smaller proportion of the screen/symptomatic patients were satisfied with their wait (72.5% screen/ screen, 56.4% screen/symptomatic, 100% no screen/ screen, 90.9% no screen/symptomatic; p = 0.048). A larger proportion of screen/symptomatic prostate cancer patients had long waits (>104.5 days: 41.3% screen/screen, 92.0% screen/symptomatic, 46.0% no screen/screen, 40.0% no screen/symptomatic; p = 0.011) and a smaller proportion of screen/ symptomatic patients were satisfied with their wait (71.2% screen/screen, 30.8% screen/symptomatic, 76.9% no screen/screen, 90.9% no screen/symptomatic; p = 0.008).

Conclusions: Diagnosis-related wait times and satisfaction were poorest among patients who received regular screening tests but whose cancer was not detected by those tests.

Keywords: Cancer screening; breast cancer; patient satisfaction; prostate cancer; wait times.

PubMed Disclaimer

References

    1. Crispo A, Barba M, D’Aituo G, et al. Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series. BMC Cancer. 2013;13:15. doi: 10.1186/1471-2407-13-15. - DOI - PMC - PubMed
    1. Faria EF, Carvalhal GF, Vieira RA, et al. Comparison of clinical and pathologic findings of prostate cancers detected through screening versus conventional referral in Brazil. Clin Genitourin Cancer. 2011;9:104–8. doi: 10.1016/j.clgc.2011.06.004. - DOI - PubMed
    1. Hua L, Qiao D, Xu B, et al. Clinical and pathological characteristics of screen-detected versus clinically diagnosed prostate cancer in Nanjing, China. Med Oncol. 2011;28:357–64. doi: 10.1007/s12032-009-9409-3. - DOI - PubMed
    1. Kim J, Lee S, Bae S, et al. Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes. Breast Cancer Res Treat. 2012;131:527–40. doi: 10.1007/s10549-011-1836-0. - DOI - PubMed
    1. Pande R, Froggatt P, Baragwanath P, Harmston C. Survival outcome of patients with screening vs. symptomatically detected colorectal cancers. Colorectal Dis. 2012;15:74–9. doi: 10.1111/j.1463-1318.2012.03120.x. - DOI - PubMed

LinkOut - more resources